KETAMINE could benefit patients with Parkinson's disease, potentially helping the motor cortex to regain some control over movement, new research from the University of Arizona has uncovered.
The common anaesthetic could help disrupt abnormal repetitive electrical patterns in the brain that occur during dyskinesia, involuntary movements that develop after years of treatment with levodopa - see the study here.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Jan 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Jan 25
